Emergency Medicine Cardiac Research and Education Group




ACTION Registry
ACTION Registry®–GWTG™ is a national, risk-adjusted, outcomes-based quality improvement program that helps participating facilities measure and improve care for high-risk ACS patients with STEMI and NSTEMI. The result of the collaboration between the two leading national coronary artery disease registries, the NCDR® ACTION Registry® and the American Heart Association (AHA) Get With The GuidelinesSM-CAD Registry, ACTION Registry–GWTG will be the largest, most comprehensive national cardiovascular patient database ever developed by the medical profession.

Combining the strengths of the two programs, ACTION Registry–GWTG will collect a comprehensive set of data elements that provide healthcare professionals and their facilities with the information they need to monitor and improve adherence to the most current, science-based ACC/AHA treatment guidelines. Participation will greatly facilitate quality improvement efforts, optimize clinical care, and improve clinical outcomes for acute coronary syndrome patients.

Visit How To Join to request additional information or to download an enrollment package. Or, visit the ACTION website for more information.


W. Brian Gibler, MD, Chairman
University of Cincinnati
Cincinnati, Ohio


V. Anantharaman, MD
Singapore General Hospital
Singapore


Tom P. Aufderheide, MD
Medical College of Wisconsin
Milwaukee, Wisconsin


Roberto R. Bassan, MD
Pro-Cardiaco Hospital
Rio de Janeiro, Brazil


Andra L. Blomkalns, MD
University of Cincinnati
Cincinnati, Ohio


Gerald X. Brogan, MD, FACEP
North Shore University Hospital
Plainview, New York


David F. M. Brown, MD, FACEP
Massachusetts General Hospital
Boston, Massachusetts


Charles B. Cairns, MD
Duke Clinical Research Institute
Durham, North Carolina


Douglas M. Char, MD
Washington University School of Medicine
St. Louis, Missouri


Sean P. Collins, MD
University of Cincinnati
Cincinnati, Ohio


Herman H. Delooz, MD, PhD
University Hospital Gasthuisberg
Leuven, Belgium


Deborah B. Diercks, MD
U.C. Davis Medical Center
Sacramento, California


Gregory J. Fermann, MD
University of Cincinnati
Cincinnati, Ohio


Francis M. Fesmire, MD
Erlanger Medical Center
Chattanooga, Tennessee


J. Lee Garvey, MD
Carolinas Medical Center
Charlotte, North Carolina


Jin H. Han, MD
Vanderbilt University Medical Center
Nashville, Tennessee


Katherine L. Heilpern, MD
Emory University School of Medicine
Atlanta, Geogia


Brian Hiestand, MD, MPH
The Ohio State University
Columbus, Ohio


James W. Hoekstra, MD
Wake Forest University
Winston Salem, North Carolina


Judd E. Hollander, MD
University of Pennsylvania Hospital
Philadelphia, Pennsylvania


Brian R. Holroyd, MD
University of Alberta Hospitals
Edmonton, Alberta, Canada


Shingo Hori, MD
Keio University
Tokyo, Japan

Ray E. Jackson, MD
William Beaumont Hospital
Royal Oak, MI


J. Douglas Kirk, MD
U.C. Davis Medical Center
Sacramento, California


Phillip D. Levy, MD
Wayne State University
Detroit, MI


Christopher R. Lindsell, PhD
University of Cincinnati
Cincinnati, Ohio


Chad V. Miller, MD
Wake Forest University
Winston Salem, NC


Richard M. Nowak, MD
Henry Ford Hospital
Detroit, MI


Masatoshi Oba, MD, PhD
Osaki Citizens Hospital
Osaki, Japan


Gunnar Öhlén, MD, PhD
Karolinska University Hospital
Stockholm, Sweden


Brian O'Neil, MD
William Beaumont Hospitals
Detroit, MI


Joseph P. Ornato, MD
Medical College of Virginia
Richmond, VA


Arthur M. Pancioli, MD
University of Cincinnati
Cincinnati, Ohio


William F. Peacock, MD
The Cleveland Clinic Foundation
Cleveland, Ohio


Charles V. Pollack, MA, MD
University of Pennsylvania Hospital
Philadelphia, Pennsylvania


Emanuel P. Rivers, MD, PhD
Henry Ford Hospital
Detroit, MI


Ivan C. Rokos, MD
Geffen School of Medicine at UCLA
Los Angeles, CA


Francois P. Sarasin, MD
Hospital Cantonal
Geneva, Switzerland


Harry R. Severance, MD
University of South Florida
Tampa, FL


Corey M. Slovis, MD
Vanderbilt University
Nashville, Tennessee


Alan B. Storrow, MD
Vanderbilt University
Nashville, Tennessee


Richard L. Summers, MD
University of Mississippi
Jackson, Mississippi


James E. Weber, MD
University of Michigan/Hurley Medical Center
Flint, Michigan







Legal information

EMCREG™ - International
4555 Lake Forest Drive
Suite 650
Cincinnati, Ohio 45242

Fell free to contact us toll-free at 1-866-4EMCREG (436-2734)



Advanced Search

5 March 2010
Computed tomography angiography provides important additional prognostic information, but it's role in clinical practice is still not known.
11 February 2010
Researchers report that a novel method for using natriuretic-peptide testing can optimize postdischarge therapy after acute heart-failure decompensation, reduce hospitalization, and improve outcomes.
28 January 2010
Study results show that the TIMI risk score predicts outcomes in emergency department with suspected ACS.
28 January 2010
Serial measurement of NT-proBNP predicts new-onset heart failure and cardiovascular mortality in elderly.
15 January 2010
Results of the PLATO trial show that the reversible P2Y12 inhibitor ticagrelor reduces death and cardiovascular events compared with clopidogrel therapy in ACS patients.
15 January 2010
Individual risk profiling of ACS patients could optimize therapeutic treatment choices.
5 January 2010
Study shows that high sensitive cardiac troponin I level is a useful prognostic marker of mortality in chronic heart failure patients.
23 December 2009
The largest and most comprehensive meta-analysis ever concludes that CRP is unlikely to be a causal factor for cardiovascular disease.
16 December 2009
Research shows that a substantial number of STEMI patients still receive fibrinolytic therapy at PCI capable centers.
11 December 2009
Denmark researchers report in Lancet that relative risk for hospitalization for bleeding increased with all drug combinations and with each additional drug used.
3 December 2009
Researchers report that prehospital triage significantly reduces treatment delay and improves outcomes in STEMI patients who undergo PCI.
30 November 2009
Researchers report that the to reperfusion, beginning with symptom onset time, determines the extent of reversible myocardial injury in STEMI patients undergoing PCI.
NEWS ARCHIVES:
©Copyright EMCREG-International™. All rights reserved